<?xml version="1.0" encoding="us-ascii"?><rss version="2.0"><channel><title>Biologic Market Research Reports</title><link>http://www.marketreportsonline.com/Alpha_Report.aspx?q=BIOLOGIC</link><description>Biologic Market Reports Online XML Feed</description><item><title>China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products</title><link>http://www.marketreportsonline.com/239043-china-pharmaceuti.html</link><description>This report provides a comprehensive and thorough knowledge of application for imported biological product registration with the Chinese drug regulatory authorities to guide overseas pharmaceutical manufacturers and producers to achieve a successful application for their products entry into the Chinese drug market.The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and complex. In China, the development of biopharmaceutical industry is far behind the developed countries. The requirements of materials and clinical trials for registration application of biopharma...</description><pubDate>Fri, 10 May 2013 00:00:00 GMT</pubDate></item><item><title>rEVO Biologics - Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/237101-revo-biologics-st.html</link><description>rEVO Biologics (rEVO), formerly known as GTC Biotherapeutics, Inc., is a rare disease company. It develops and delivers cost effective first and next-generation human therapeutic proteins. It utilizes its proprietary rPRO technology platform to produce a recombinant form of specified human protein in animals milk. rEVO''s lead product ATryn (antithrombin) is a recombinant indicated to prevent peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients. The company''s product pipeline comprises ATryn (antithrombin), indicated to treat preeclampsia, FVIIa (recombinant), for the treatment of hemophilia, next-gen ublituximab, to treat hematolog...</description><pubDate>Tue, 09 Apr 2013 00:00:00 GMT</pubDate></item><item><title>Daesung Microbiological Labs, Co., Ltd. (036480) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/230612-daesung-microbiol.html</link><description>This comprehensive SWOT profile of Daesung Microbiological Labs, Co., Ltd. provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>China Meihua Biological Technology PLC (CMBP) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/235800-china-meihua-biol.html</link><description>This comprehensive SWOT profile of China Meihua Biological Technology PLC  provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of company analysts w...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/228972-china-biologic-pr.html</link><description>This comprehensive SWOT profile of China Biologic Products, Inc.  provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of company ...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>Chongqing Zhifei Biological Products Co., Ltd. (300122) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/235535-chongqing-zhifei-.html</link><description>This comprehensive SWOT profile of Chongqing Zhifei Biological Products Co., Ltd.  provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of company an...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (002219) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/170483-gansu-duyiwei-bio.html</link><description>This comprehensive SWOT profile of Gansu Duyiwei Biological Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the company&amp;rsquo;s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company&amp;rsquo;s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData&amp;rsquo;s &amp;lsquo;Profile on Demand&amp;rsquo; service, covering over 50,000 of the world&amp;rsquo;s leading companies. O...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>GlaxoSmithKline Biologicals S.A. - Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/171242-glaxosmithkline-b.html</link><description>This comprehensive SWOT profile of GlaxoSmithKline Biologicals S.A. provides you with an in-depth strategic analysis of the company&amp;#39;s businesses and operations. The profile will give you a clear and an unbiased view of the company&amp;#39;s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the &amp;#39;Profile on Demand&amp;#39; Service, covering over 50,000 of the world&amp;#39;s leading companies. Once purchased, We will comprehensively research and author a full strategic a...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>General Biologicals Corporation (4117) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/171528-general-biologica.html</link><description>This comprehensive SWOT profile of General Biologicals Corporation provides you an in-depth strategic analysis of the company&amp;rsquo;s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company&amp;rsquo;s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData&amp;rsquo;s &amp;lsquo;Profile on Demand&amp;rsquo; service, covering over 50,000 of the world&amp;rsquo;s leading companies. Once purchased, Glo...</description><pubDate>Fri, 08 Mar 2013 00:00:00 GMT</pubDate></item><item><title>The 2013-2018 Outlook for Biological Veterinary Vaccines, Bacterins, Toxoids, Other Antigens, and Other Biological Products in Greater China</title><link>http://www.marketreportsonline.com/238810-the-2013-2018-out.html</link><description>This econometric study covers the latent demand outlook for biological veterinary vaccines, bacterins, toxoids, other antigens, and other biological products across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as ?regions?). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China ...</description><pubDate>Thu, 10 Jan 2013 00:00:00 GMT</pubDate></item><item><title>The 2013-2018 Outlook for Lawn and Garden Biological Preparations in Greater China</title><link>http://www.marketreportsonline.com/246510-the-2013-2018-out.html</link><description>This econometric study covers the latent demand outlook for lawn and garden biological preparations across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as ?regions?). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 500 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of ?econo...</description><pubDate>Thu, 10 Jan 2013 00:00:00 GMT</pubDate></item><item><title>Advanced Biologics Corporation - Product Pipeline Analysis</title><link>http://www.marketreportsonline.com/213527-advanced-biologic.html</link><description>Advanced Biologics Corporation (ABC) is a medical device company which carries out the development of innovative and clinically relevant biologic solutions across wide degree of medical devices. The OsteoAMP family of /conductive products are the first line of orthobiologic offerings produced by the company. Its products include OsteoMEM and OsteoAMP. OsteoMEM is a ultra porous shaped memory scaffold with a ''first of its kind'', unique antibacterial feature. OsteoAMP a new biologic growth factor technology of the company that is proving to be a alternative to rhBMP-2 and the allograft derived stem cell matrices. ABC is headquartered in Ladera Ranch, California, the US....</description><pubDate>Thu, 27 Dec 2012 00:00:00 GMT</pubDate></item><item><title>RTI Biologics, Inc. (RTIX) - Product Pipeline Analysis</title><link>http://www.marketreportsonline.com/209911-rti-biologics-inc.html</link><description>RTI Biologics, Inc. (RTI), formerly Regeneration Technologies, Inc., is a medical device company. It provides tissue-based solutions to repair and promote the natural healing of human bone and other human tissues. The company produces Allograft tissue and Xenograft tissue utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes. It has manufacturing facilities in Alachua, Florida and Neunkirchen, Germany. RTI has non-exclusive relationships with some of the leading pharmaceutical companies to market its products. The company is headquartered in Florida, the US.The company is focused on rapid, cost-effective delivery of quality products to a diverse grou...</description><pubDate>Wed, 28 Nov 2012 00:00:00 GMT</pubDate></item><item><title>RTI Biologics, Inc. Market Share Analysis</title><link>http://www.marketreportsonline.com/205366-rti-biologics-inc.html</link><description>RTI Biologics, Inc. Market Share AnalysisGlobalData?s new report, ?RTI Biologics, Inc. Market Share Analysis? provides in-depth information on RTI Biologics, Inc.?s market position in the orthobiologics market. The report also provides data and information on the overall competitive landscape within the orthobiologics market. The report is supplemented with global corporate-level profile with information on the company?s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.This report is built using data and information sourced from proprietary databases, primary and secondary ...</description><pubDate>Wed, 31 Oct 2012 00:00:00 GMT</pubDate></item><item><title>CCC - Mechanical Biological Treatment (MBT) Plant - Cumbria - Construction Project Profile</title><link>http://www.marketreportsonline.com/194060-ccc-mechanical-bi.html</link><description>SynopsisThe CCC - Mechanical Biological Treatment (MBT) Plant - Cumbria - Construction Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts.The CCC - Mechanical Biological Treatment (MBT) Plant - Cumbria - Construction Project Profile is part of World Market Intelligence''s database of 25,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $50 million and key contact d...</description><pubDate>Wed, 19 Sep 2012 00:00:00 GMT</pubDate></item><item><title>Bone Biologics, Inc. - Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/193043-bone-biologics-in.html</link><description>Bone Biologics, Inc. (Bone Biologics) is a biotechnology company. The company manufactures orthobiologic products. It develops bone and cartilage regeneration technologies. Its products include University of California Bone-1 (UCB-1) technology, a skeletal specific growth factor; and University of California Scaffold-1 (UCS-1), a biomaterial that potentates and regulates growth factor activity in bone regeneration. The company''s technology has appplication in various surgical specialties, namely, spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. These products allow unprecedented regulation over skeletal tissue formation a...</description><pubDate>Mon, 10 Sep 2012 00:00:00 GMT</pubDate></item><item><title>Alpha Biologics Sdn Bhd - Pharmaceuticals &amp; Healthcare - Deals and Alliances Profile</title><link>http://www.marketreportsonline.com/189000-alpha-biologics-s.html</link><description>Alpha Biologics Sdn Bhd - Pharmaceuticals &amp; Healthcare - Deals and Alliances ProfileAlpha Biologics Sdn Bhd (Alpha Biologics) is a pharmaceutical and healthcare company, based in Malaysia. It provides contract bio-manufacturing services. The company supplies mammalian cell proteins such as monoclonal antibodies, recombinant proteins, and other cell-derived products. The company?s process development services include small-scale production for quality assessmen, expression plasmid expression, mammalian cell transfection and clonal selection, cell line suspension and serum-free adaptation, cell line cloning and high expression selection and assay development for specif...</description><pubDate>Fri, 24 Aug 2012 00:00:00 GMT</pubDate></item><item><title>China Biologic Products, Inc. (CBPO) - Pharmaceuticals &amp; Healthcare - Deals and Alliances Profile</title><link>http://www.marketreportsonline.com/188558-china-biologic-pr.html</link><description>China Biologic Products, Inc. (CBPO) - Pharmaceuticals &amp; Healthcare - Deals and Alliances ProfileChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. It is engaged in the research, development, production and manufacturing of plasma-based pharmaceutical product products for the prevention and treatment of various diseases. The company operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi''an Huitian Blood Products Co., Ltd. The product portfolio of the company consists of human albumin, human immunoglobulin, t...</description><pubDate>Tue, 14 Aug 2012 00:00:00 GMT</pubDate></item><item><title>RTI Biologics, Inc. (RTIX) - Medical Equipment - Deals and Alliances Profile</title><link>http://www.marketreportsonline.com/188410-rti-biologics-inc.html</link><description>RTI Biologics, Inc. (RTIX) - Medical Equipment - Deals and Alliances ProfileRTI Biologics, Inc. (RTI), formerly Regeneration Technologies, Inc., is a medical device company. It provides tissue-based solutions to repair and promote the natural healing of human bone and other human tissues. The company produces Allograft tissue and Xenograft tissue utilizing proprietary BIOCLEANSE and TUTOPLAST sterilization processes. It has manufacturing facilities in Alachua, Florida and Neunkirchen, Germany. RTI has non-exclusive relationships with some of the leading pharmaceutical companies to market its products. The company is headquartered in Florida, the US.The co...</description><pubDate>Tue, 14 Aug 2012 00:00:00 GMT</pubDate></item><item><title>ReGen Biologics, Inc. (RGBO) - Medical Equipment - Deals and Alliances Profile</title><link>http://www.marketreportsonline.com/188408-regen-biologics-i.html</link><description>ReGen Biologics, Inc. (RGBO) - Medical Equipment - Deals and Alliances ProfileReGen Biologics, Inc. (ReGen) is a public medial equipment company. It primarily focuses on developing, manufacturing and marketing tissue growth and repair products for the US and other parts of the world. The company concentrates on providing minimally invasive implants and medical devices that aid in new tissue growth to replace damaged or removed soft tissue resulting in regaining mobility. Its proprietary collagen matrix technology finds applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. The company''s product menaflex a biologically-derived implant ...</description><pubDate>Tue, 14 Aug 2012 00:00:00 GMT</pubDate></item><item><title>Immuno-Biological Laboratories Co., Ltd. (4570) - Medical Equipment - Deals and Alliances Profile</title><link>http://www.marketreportsonline.com/189126-immuno-biological.html</link><description>Immuno-Biological Laboratories Co., Ltd. (4570) - Medical Equipment - Deals and Alliances ProfileImmuno-Biological Laboratories Co., Ltd. (IBL) is engaged in the research, development, manufacture and sale of pharmaceutical products. It specializes in the development of antibodies against proteins related to various diseases that include cancers, autoimmune diseases, and disorders of the brain and nervous system. The company operates through three business segments namely Research Test Reagent segment, Laboratory Animal segment and drug discovery-related business. The Research Test Reagent segment cells antibody-associated test reagents, such as antibodies and enzyme...</description><pubDate>Thu, 09 Aug 2012 00:00:00 GMT</pubDate></item><item><title>Avaxia Biologics, Inc. ? Product Pipeline Review ? 2012</title><link>http://www.marketreportsonline.com/179698-avaxia-biologics-.html</link><description>Avaxia Biologics, Inc. ? Product Pipeline Review ? 2012Global Market Direct?s pharmaceuticals report, ?Avaxia Biologics, Inc. - Product Pipeline Review - 2012? provides data on the Avaxia Biologics, Inc.?s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct?s proprietary databases, Avaxia Biologics, Inc.?s corporate website, SEC filings, investor presentations and featured press releases, both from Avaxia Biologics, Inc. and industry-specific third...</description><pubDate>Mon, 16 Jul 2012 00:00:00 GMT</pubDate></item><item><title>Hualan Biological Engineering, Inc. (002007) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/170432-hualan-biological.html</link><description>This comprehensive SWOT profile of Hualan Biological Engineering, Inc.  provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of company analysts will...</description><pubDate>Fri, 15 Jun 2012 00:00:00 GMT</pubDate></item><item><title>Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic SWOT Analysis Review</title><link>http://www.marketreportsonline.com/170469-immuno-biological.html</link><description>This comprehensive SWOT profile of Immuno-Biological Laboratories Co., Ltd.  provides you an in-depth strategic analysis of the company?s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company?s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of GlobalData?s ?Profile on Demand? service, covering over 50,000 of the world?s leading companies. Once purchased, GlobalData?s highly qualified team of company analysts...</description><pubDate>Fri, 15 Jun 2012 00:00:00 GMT</pubDate></item><item><title>The Chinese R&amp;D Landscape - Analysis of Biological Material</title><link>http://www.marketreportsonline.com/168324-the-chinese-rd-la.html</link><description>R&amp;amp;D in China in the field of analysis of biological materials* has surged over the last decade. This report seeks to answer the following questions related to this surge in R&amp;amp;D:Where in China does the R&amp;amp;D in the field of analysis of biological materials take place?What companies and academic institutions in China are driving this R&amp;amp;D effort?What has been the focus of Chinese R&amp;amp;D in the field of analysis of biological materials?The foundation for the study has been the complete database of Chinese invention patents and patent applications from the State Intellectual Property Office of China. This database has been supplemented with geog...</description><pubDate>Fri, 01 Jun 2012 00:00:00 GMT</pubDate></item></channel></rss>